ME Therapeutics Holdings Inc.
METXF
$2.95
$0.000.00%
OTC PK
02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.38M | 946.60K | 1.11M | 1.21M | 992.80K |
Total Receivables | 16.90K | 19.00K | 12.30K | 9.60K | 5.90K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 42.20K | 60.20K | 18.70K | 2.50K | 5.90K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.44M | 1.03M | 1.14M | 1.22M | 1.00M |
|
|||||
Total Current Assets | 1.44M | 1.03M | 1.14M | 1.22M | 1.00M |
Net Property, Plant & Equipment | 170.10K | 79.80K | 100.00 | 100.00 | 100.00 |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.50K | 7.80K | -- | -- | -- |
Total Assets | 1.62M | 1.11M | 1.14M | 1.22M | 1.00M |
|
|||||
Total Accounts Payable | 5.70K | 64.40K | 34.20K | 10.10K | -- |
Total Accrued Expenses | 26.90K | 22.90K | -- | 21.40K | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 38.60K | 38.10K | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | 12.40K | 2.70K | -- |
Total Other Current Liabilities | -- | -- | 12.40K | 2.70K | -- |
Total Current Liabilities | 71.30K | 125.40K | 46.60K | 34.30K | -- |
|
|||||
Total Current Liabilities | 71.30K | 125.40K | 46.60K | 34.30K | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 29.40K | 41.00K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 100.70K | 166.40K | 46.60K | 34.30K | -- |
|
|||||
Common Stock & APIC | 5.95M | 4.36M | 4.53M | 4.48M | 3.36M |
Retained Earnings | -6.26M | -6.31M | -6.33M | -6.03M | -5.69M |
Treasury Stock & Other | 1.83M | 2.89M | 2.89M | 2.74M | 3.34M |
Total Common Equity | 1.52M | 947.10K | 1.09M | 1.19M | 1.00M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.52M | 947.10K | 1.09M | 1.19M | 1.00M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.52M | 947.10K | 1.09M | 1.19M | 1.00M |
|